| | | | | | | | | | | | | | | | | | | | | | | |
| UNITED STATES |
| SECURITIES AND EXCHANGE COMMISSION |
| Washington, D.C. 20549 |
| | | | | | | |
| SCHEDULE 14C |
| | | | | | | |
| SCHEDULE 14C INFORMATION |
| | | | | | | |
| Information Statement Pursuant to Section 14(c) of |
| the Securities Exchange Act of 1934 (Amendment No. ) |
| | | | | | | |
| | | | | | | |
| Check the appropriate box: |
| ☐ | Preliminary Information Statement |
| ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) |
| ☐ | Definitive Information Statement |
| ☒ | Definitive Additional Materials |
| | | | | | | |
| United States Cellular Corporation |
| (Name of Registrant as Specified In Its Charter) |
| | | | | | | |
| Payment of Filing Fee (Check the appropriate box): |
| ☒ | No fee required. |
| ☐ | Fee paid previously with preliminary materials. |
| ☐ | Fee computed on table in exhibit required by Item 25(b) of Schedule 14A (17 CFR 240.14a–101) per Item 1 of this Schedule and Exchange Act Rules 14c–5(g) and 0–11. |
